156 related articles for article (PubMed ID: 21756244)
1. Immunological aspects of scorpion toxins: current status and perspectives.
Bouhaouala-Zahar B; Ben Abderrazek R; Hmila I; Abidi N; Muyldermans S; El Ayeb M
Inflamm Allergy Drug Targets; 2011 Oct; 10(5):358-68. PubMed ID: 21756244
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical studies of toxin-specific nanobodies: evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming.
Hmila I; Cosyns B; Tounsi H; Roosens B; Caveliers V; Abderrazek RB; Boubaker S; Muyldermans S; El Ayeb M; Bouhaouala-Zahar B; Lahoutte T
Toxicol Appl Pharmacol; 2012 Oct; 264(2):222-31. PubMed ID: 22968189
[TBL] [Abstract][Full Text] [Related]
3. [Scorpion envenomation].
Abroug F
Tunis Med; 2001 May; 79(5):329-34. PubMed ID: 11515477
[No Abstract] [Full Text] [Related]
4. Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins.
Meddeb-Mouelhi F; Bouhaouala-Zahar B; Benlasfar Z; Hammadi M; Mejri T; Moslah M; Karoui H; Khorchani T; El Ayeb M
Toxicon; 2003 Dec; 42(7):785-91. PubMed ID: 14757210
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use.
Ismail M; Abd-Elsalam MA
Toxicon; 1998 Nov; 36(11):1523-8. PubMed ID: 9792168
[TBL] [Abstract][Full Text] [Related]
6. Nanobodies as novel therapeutic agents in envenomation.
Alirahimi E; Kazemi-Lomedasht F; Shahbazzadeh D; Habibi-Anbouhi M; Hosseininejad Chafi M; Sotoudeh N; Ghaderi H; Muyldermans S; Behdani M
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2955-2965. PubMed ID: 30309831
[TBL] [Abstract][Full Text] [Related]
7. Development of a new approach of immunotherapy against scorpion envenoming: Avian IgYs an alternative to equine IgGs.
Sifi A; Adi-Bessalem S; Laraba-Djebari F
Int Immunopharmacol; 2018 Aug; 61():256-265. PubMed ID: 29902709
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for scorpion envenoming in Brazil.
Rezende NA; Amaral CF; Freire-Maia L
Toxicon; 1998 Nov; 36(11):1507-13. PubMed ID: 9792165
[TBL] [Abstract][Full Text] [Related]
9. Antivenom therapy for scorpion bites.
Arya SC
Toxicon; 2000 Dec; 38(12):1627-8. PubMed ID: 11182940
[No Abstract] [Full Text] [Related]
10. Is antivenom the most successful therapy in scorpion victims?
Gueron M; Ilia R
Toxicon; 1999 Dec; 37(12):1655-7. PubMed ID: 10519644
[No Abstract] [Full Text] [Related]
11. The venom of the scorpion Centruroides limpidus, which causes the highest number of stings in Mexico, is neutralized by two recombinant antibody fragments.
Fernández-Taboada G; Riaño-Umbarila L; Olvera-Rodríguez A; Gómez-Ramírez IV; Losoya-Uribe LF; Becerril B
Mol Immunol; 2021 Sep; 137():247-255. PubMed ID: 34298407
[TBL] [Abstract][Full Text] [Related]
12. Treatment of scorpion envenoming should include both a potent specific antivenom and support of vital functions.
Amaral CF; Rezende NA
Toxicon; 2000 Aug; 38(8):1005-7. PubMed ID: 10836905
[No Abstract] [Full Text] [Related]
13. A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation.
Yardehnavi N; Behdani M; Bagheri KP; Mahmoodzadeh A; Khanahmad H; Shahbazzadeh D; Habibi-Anbouhi M; Hassanzadeh Ghassabeh G; Muyldermans S
FASEB J; 2014 Sep; 28(9):4004-14. PubMed ID: 24891523
[TBL] [Abstract][Full Text] [Related]
14. Scorpion envenomation.
Isbister GK; Bawaskar HS
N Engl J Med; 2014 Jul; 371(5):457-63. PubMed ID: 25075837
[No Abstract] [Full Text] [Related]
15. Production of recombinant scorpion antivenoms in E. coli: current state and perspectives.
Alonso Villela SM; Kraïem-Ghezal H; Bouhaouala-Zahar B; Bideaux C; Aceves Lara CA; Fillaudeau L
Appl Microbiol Biotechnol; 2023 Jul; 107(13):4133-4152. PubMed ID: 37199752
[TBL] [Abstract][Full Text] [Related]
16. Perspectives and recommendations towards evidence-based health care for scorpion sting envenoming in the Brazilian Amazon: A comprehensive review.
Monteiro WM; Gomes J; Fé N; Mendonça da Silva I; Lacerda M; Alencar A; Seabra de Farias A; Val F; de Souza Sampaio V; Cardoso de Melo G; Pardal P; Mota da Silva A; Bernarde PS; Carlos de Lima Ferreira L; Gutierrez JM; de Almeida Gonçalves Sachett J; Fan HW
Toxicon; 2019 Nov; 169():68-80. PubMed ID: 31494205
[TBL] [Abstract][Full Text] [Related]
17. Development of protective agent against Hottentotta saulcyi venom using camelid single-domain antibody.
Darvish M; Behdani M; Shokrgozar MA; Pooshang-Bagheri K; Shahbazzadeh D
Mol Immunol; 2015 Dec; 68(2 Pt B):412-20. PubMed ID: 26468036
[TBL] [Abstract][Full Text] [Related]
18. Scorpion envenomation and serotherapy in Morocco.
Ghalim N; El-Hafny B; Sebti F; Heikel J; Lazar N; Moustanir R; Benslimane A
Am J Trop Med Hyg; 2000 Feb; 62(2):277-83. PubMed ID: 10813485
[TBL] [Abstract][Full Text] [Related]
19. Biotechnological Trends in Spider and Scorpion Antivenom Development.
Laustsen AH; Solà M; Jappe EC; Oscoz S; Lauridsen LP; Engmark M
Toxins (Basel); 2016 Jul; 8(8):. PubMed ID: 27455327
[TBL] [Abstract][Full Text] [Related]
20. An equilibrium ELISA for the dosage of Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpion venoms: set up and calibration.
Krifi MN; el Ayeb M
Arch Inst Pasteur Tunis; 1998; 75(3-4):185-94. PubMed ID: 14666744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
